Search

Your search keyword '"J, Fueyo"' showing total 204 results

Search Constraints

Start Over You searched for: Author "J, Fueyo" Remove constraint Author: "J, Fueyo"
204 results on '"J, Fueyo"'

Search Results

1. TUMOR MODELS (IN VIVO/IN VITRO)

2. IMMUNOLOGY RESEARCH

3. LAB-ANGIOGENESIS AND INVASION

4. HIGH GRADE GLIOMAS

5. Novel therapies for high-grade gliomas: A vision for future

6. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

7. METABOLIC PATHWAYS

8. Pre-clinical Experimental Therapeutics and Pharmacology

9. LAB-PEDIATRICS LABORATORY RESEARCH

10. STEM CELLS

11. ChemInform Abstract: Alkylation of 3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydroindole with Bromoesters: Benzenesulfonyl as Convenient Nitrogen Protecting Group

12. ChemInform Abstract: Synthesis, Hypotensive, and Diuretic Activities of Several 3-Hydrazino- 5,6-dihydrobenzo(h)cinnolines. Part 10. Pyridazine Derivatives

13. ChemInform Abstract: Synthesis and Affinities for Dopamine (D2) and 5-Hydroxytryptamine (5- HT2A) Receptors of 1-(Benzoylpropyl)-4-(1-oxocycloalkyl-2-ethyl) piperazines as Cyclic Butyrophenone Derivatives

14. Tie2: a journey from normal angiogenesis to cancer and beyond

15. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2

16. Delivery of cell cycle genes to block astrocytoma growth

17. [Oncolytic adenovirus for the treatment of cerebral tumors: past, present and future]

18. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency

19. Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo

20. [Molecular control of the cellular cycle and apoptosis: new treatments for gliomas]

21. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas

22. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis

23. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells

24. A frequent polymorphism in exon 1 of the p16/CDKN2 gene

25. Synthesis and potential anthelmintic activity of methyl-5-(4-salicyloyl-piperazin-1-yl)-benzimidazole-2-carbamates

26. Antiserotoninergic activity of 2-aminoethylbenzocyclanones in rat aorta: structure-activity relationships

28. Negative inotropic effect induced by diethylamiloride (DEA) in rabbit myocardium

31. Alkylation of 3-Ethyl-2-methyl-4-oxo-4,5,6,7-tetrahydroindole with Bromoesters: Benzenesulfonyl as Convenient Nitrogen Protecting Group

32. Analysis of Plastic Flow Through Inclined Planes in Plane Strain

34. [Bone metastases as the initial manifestation of hepatocarcinoma]

35. Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer.

36. The emerging field of viroimmunotherapy for pediatric brain tumors.

37. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

39. Oncolytic adenoviruses and immunopeptidomics: a convenient marriage.

40. Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice.

41. Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas.

42. Targeting Innate Immunity in Glioma Therapy.

43. Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics.

44. Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.

45. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

46. Remission of liquid tumors and SARS-CoV-2 infection: A literature review.

47. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.

48. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.

49. Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.

50. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.

Catalog

Books, media, physical & digital resources